Degarelix therapy for prostate cancer in a real-world setting: experience from the German IQUO (Association for Uro-Oncological Quality Assurance) Firmagon® registry
Crossref DOI link: https://doi.org/10.1186/s12894-015-0116-4
Published Online: 2015-12-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Geiges, Götz
Harms, Thomas
Rodemer, Gerald
Eckert, Ralf
König, Frank
Eichenauer, Rolf
Schroder, Jörg
License valid from 2015-12-01